Fact CheckerSign in

NCT06382415Completed

Organ/Space Surgical Site Infection and Recurrence and Survival in Rectal Cancer Surgery

Effect of Organ/Space Surgical Site Infection After Rectal Cancer Resection on Five-year Recurrence and Survival Rates. A Population-based Cohort Study of 2208 Patients

Source: ClinicalTrials.gov · Last updated 13 May 2024

Brief summary (registry, in English)

In rectal cancer surgery, the organ/space surgical site infection (O/S-SSI) has an impact on patient's prognosis. Its influence in the oncologic outcomes remains controversial. The main objective is to assess the possible effect of O/S-SSI on long-term overall survival and cancer recurrence.

Status (registry)
Completed
Study type
Observational
Enrollment
3826 (actual)
First submitted
19 Apr 2024
Start date
1 Jan 2011
Primary completion date
31 Dec 2016
Lead sponsor
Hospital de Granollers
NCT number
NCT06382415

What you commit to

  • Study type: Observational
  • Participants enrolled: 3826
  • From 1 Jan 2011 to the primary completion date, 31 Dec 2016
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Transanal local resection
  • Presence of metastases found in the diagnostic process or during the surgical procedure
  • Non-resectable tumour or palliative surgery

Other illness

  • Recurrence of the disease treated before the study period

Other

  • Emergency colorectal surgeries
  • Patients operated in private centres

Who the study is looking for

  • Patients \> 18 years old
  • Eligible patients with tumour ≤ 13 cm from anal verge, as measured by Magnetic Resonance Imaging
  • Primary adenocarcinoma
  • Oncological resection with curative intent
  • Cancer stages: I-II-III

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institut Catala D'oncologia
Coordinator of this site? Confirm its status
L'Hospitalet de LlobregatSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.